Drug Delivery Technologies Market, By Route of Administration, By Therapeutic Area, By End User, By Geography

Description

Global drug delivery technologies market is estimated to be valued at USD 44.10 Bn in 2024 and is expected to reach USD 102.01 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 12.7% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 44.10 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	12.70%	2031 Value Projection:	US$ 102.01 Bn

Figure. Drug Delivery Technologies Market Share (%), By Region 2024

Drug Delivery Technologies Market - IMG1

Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Various drug delivery technologies have been developed to improve efficacy and safety of drug molecules by protecting them from degradation and controlling their release rates. Advancements in areas such as immunotherapy, gene therapy, and precision medicine have fueled the demand for more effective drug delivery methods. The market has witnessed innovation of novel drug carrier systems such as liposomes, microspheres, nanocarriers, and other that can efficiently deliver drugs to targeted sites in the body. Furthermore, rising prevalence of chronic diseases, growth of biologics market, and increased R&D investments from key players in this field are some of the key factors expected to drive market growth during the forecast period.

Market Dynamics:

Global drug delivery technologies market is primarily driven by the rising global prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. In September 2023, according to the World Health Organization (WHO), chronic diseases accounted for approximately 60% of all reported deaths in the world in 2020. Drug delivery systems help improve the efficacy of pharmaceutical therapies and clinical outcomes of chronic patients. Furthermore, growth of the biologics market has also created opportunities for advanced drug delivery approaches for large molecule biotherapeutics. However, high costs associated with the R&D and manufacturing of novel drug delivery systems may hinder the market growth during the forecast period. Advancements in areas of nanomedicine, injectable drug delivery, and 3D printing offer lucrative opportunities for market expansion.

Key Features of the Study:

This report provides in-depth analysis of the global drug delivery technologies market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global drug delivery technologies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Johnson & Johnson Pvt. Ltd., Pfizer Inc., Novartis AG, Merck & Co., Inc., GlaxoSmithKline PLC, Sanofi S.A., Bayer AG, Abbott Laboratories, 3M Company, Antares Pharma, Alkermes PLC, Vectura Group PLC, Generex Biotechnology Corporation, F. Hoffmann-La Roche Ltd., and Medtronic PLC

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global drug delivery technologies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug delivery technologies market

Market Segmentation

Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
- Oral
- Parenteral
- Intramuscular
- Intravenous
- Intra-Arterial
- Subcutaneous
- Nasal Drug Delivery
- Ocular Drug Delivery
- Topical/Transdermal
Therapeutic Area Insights (Revenue, USD Bn, 2019 - 2031)
- Oncology
- Cardiology
- Neurology
- Immunology
- Rheumatology
- Diabetes
- Others (Infectious Diseases, etc.)
End User Insights (Revenue, USD Bn, 2019 - 2031)
- Ambulatory Surgical Clinics
- Diagnostic Centers
- Hospitals
- Homecare Settings
- Others
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Johnson & Johnson Pvt. Ltd.
- Pfizer Inc.
- Novartis AG
- Merck & Co., Inc.
- GlaxoSmithKline PLC
- Sanofi S.A.
- Bayer AG
- Abbott Laboratories
- 3M Company
- Antares Pharma
- Alkermes PLC
- Vectura Group PLC
- Generex Biotechnology Corporation
- F. Hoffmann-La Roche Ltd.
- Medtronic PLC

Product Code: CMI2690

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Drug Delivery Technologies Market, By Route of Administration
- Global Drug Delivery Technologies Market, By Therapeutic Area
- Global Drug Delivery Technologies Market, By End User
- Global Drug Delivery Technologies Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Drug Delivery Technologies Market, By Route of Administration, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Intramuscular
- Intravenous
- Intra-Arterial
- Subcutaneous
Nasal Drug Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ocular Drug Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Topical/Transdermal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Drug Delivery Technologies Market, By Therapeutic Area, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Rheumatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Infectious Diseases, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Drug Delivery Technologies Market, By End User, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Ambulatory Surgical Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Drug Delivery Technologies Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Route of Administration , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Route of Administration , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Route of Administration , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Johnson & Johnson Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
Novartis AG
Merck & Co., Inc.
GlaxoSmithKline PLC
Sanofi S.A.
Bayer AG
Abbott Laboratories
3M Company
Antares Pharma
Alkermes PLC
Vectura Group PLC
Generex Biotechnology Corporation
F. Hoffmann-La Roche Ltd.
Medtronic PLC

9. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

10. References and Research Methodology

References
Research Methodology
About us